Cathepsin proteases in toxoplasma gondii

Advances in Experimental Medicine and Biology

Volumn 712, Issue , 2011, Pages 49-61

  Dou, Zhicheng ^a   Carruthers, Vern B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CATHEPSIN B; CATHEPSIN INHIBITOR; CATHEPSIN L; CYSTEINE PROTEINASE INHIBITOR; DIPEPTIDYL PEPTIDASE I; K 11017; MESSENGER RNA; MORPHOLINUREA LEUCYL HOMOPHENYL VINYL SULFONE PHENYL; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIPROTOZOAL ACTIVITY; ANTISENSE THERAPY; ARTICLE; CATHEPSIN B GENE; CATHEPSIN C GENE; CATHEPSIN L GENE; CHROMOSOME STRUCTURE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE; GENE DISRUPTION; HUMAN; NONHUMAN; PARASITE SURVIVAL; PARASITE VIRULENCE; PH MEASUREMENT; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROCESSING; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TOXOPLASMA GONDII; TOXOPLASMOSIS; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN TRANSPORT; REVIEW; TOXOPLASMA;

AMINO ACID SEQUENCE; CATHEPSINS; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN TRANSPORT; TOXOPLASMA;

EID: 80053327216     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8414-2_4     Document Type: Article

References (57)

1. Lopez-Otin C, Bond JS. Proteases: Multifunctional enzymes in life and disease. J Biol Chem 2008; 283:30433-30437
2. Rawlings ND, Barrett AJ, Bateman A. MEROPS: The peptidase database. Nucleic Acids Res 2010; 38:D227-D233
3. Barrett AJ, Kirschke H. Cathepsin B et al. Methods Enzymol 1981; 80 Pt C:535-561
4. Kirschke H, Barrett AJ, Rawlings ND. Lysosomal Cysteine Proteases. 2nd ed. Oxford ; New York: Oxford University Press; 1998
5. Guicciardi ME, Deussing J, Miyoshi H et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000; 106:1127-1137
6. Barrett AJ, Rawlings ND, Woessner JF. Handbook of Proteolytic Enzymes. San Diego: Academic Press; 2004
7. Denhardt DT, Greenberg AH, Egan SE et al. Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential ofH-ras-transformed murine fibroblasts. Oncogene 1987; 2:55-59
8. Frade R, Rodrigues-Lima F, Huang S et al. Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. Cancer Res 1998; 58:2733-2736
9. Amuthan G, Biswas G, Zhang SY et al. Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J 2001; 20:1910-1920
10. Dluzewski AR, Rangachari K, Wilson RJM et al. Plasmodium falciparum: Protease inhibitors and inhibition of erythrocyte invasion. Exp Parasitol 1986; 62:416-422
11. Rosenthal PJ, McKerrow JH, Aikawa M et al. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J Clin Invest 1988; 82:1560-1566
12. Rosenthal PJ, McKerrow JH, Rasnick D et al. Plasmodium falciparum: Inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development. Mol Biochem Parasitol 1989; 35:177-183
13. Rosenthal PJ, Wollish WS, Palmer JT et al. Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J Clin Invest 1991; 88:1467-1472
14. Rosenthal PJ. Plasmodium falciparum: Effects ofproteinase inhibitors on globin hydrolysis by cultured malaria parasites. Exp Parasitol 1995; 80:272-281
15. Rosenthal PJ, Olson JE, Lee GK et al. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob Agents Chemother 1996; 40:1600-1603
16. Greenbaum DC, Baruch A, Grainger M et al. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 2002; 298:2002-2006
17. Sijwali PS, Rosenthal PJ. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc Natl Acad Sci USA 2004; 101:4384-4389
18. Eksi S, Czesny B, Greenbaum DC et al. Targeted disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth. Mol Microbiol 2004; 53:243-250
19. Caffrey CR, Hansell E, Lucas KD et al. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense. Mol Biochem Parasitol 2001; 118:61-73
20. Abdulla MH, O'Brien T, Mackey ZB et al. RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model. PLoS Negl Trop Dis 2008; 2:e298
21. Grab DJ, Garcia-Garcia JC, Nikolskaia OV et al. Protease activated receptor signaling is required for african trypanosome traversal of human brain microvascular endothelial cells. PLoS Negl Trop Dis 2009; 3:e479
22. Mackey ZB, O'Brien TC, Greenbaum DC et al. A cathepsin B-like protease is required for host protein degradation in Trypanosoma brucei. J Biol Chem 2004; 279:48426-48433
23. O'Brien TC, Mackey ZB, Fetter RD et al. A parasite cysteine protease is key to host protein degradation and iron acquisition. J Biol Chem 2008; 283:28934-28943
24. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363:1965-1976
25. Dobrowolski JM, Sibley LD. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 1996; 84:933-939
26. Carruthers VB. Proteolysis and Toxoplasma invasion. Int J Parasitol 2006; 36:595-600
27. Hakansson S, Charron AJ, Sibley LD. Toxoplasma evacuoles: A two-step process of secretion and fusion forms the parasitophorous vacuole. EMBO J 2001; 20:3132-3144
28. VK, Qi H, Beckers CJ et al. The protozoan parasite Toxoplasma gondii targets proteins to dense granules and the vacuolar space using both conserved and unusual mechanisms. J Cell Biol 1998; 141:1323-1333
29. Shaw MK, He CY, Roos DS et al. Proteasome inhibitors block intracellular growth and replication of Toxoplasma gondii. Parasitology 2000; 121 ( Pt 1):35-47
30. Que X, Ngo H, Lawton J et al. The cathepsin B of Toxoplasma gondii, toxopain-1, is critical for parasite invasion and rhoptry protein processing. J Biol Chem 2002; 277:25791-25797
31. Teo CF, Zhou XW, Bogyo M et al. Cysteine protease inhibitors block Toxoplasma gondii microneme secretion and cell invasion. Antimicrob Agents Chemother 2007; 51:679-688
32. Larson ET, Parussini F, Huynh MH et al. Toxoplasma gondii cathepsin l is the primary target of the invasion inhibitory compound LHVS. J Biol Chem 2009
33. Parussini F, Coppens I, Shah PP et al. Cathepsin L occupies a vacuolar compartment and is a protein maturase within the endo/exocytic system of Toxoplasma gondii. Mol Microbiol 2010; in press.
34. Miranda K, Pace DA, Cintron R et al. Characterization of a novel organelle in Toxoplasma gondii with similar composition and function to the plant vacuole. Mol Microbiol 2010
35. Huang R, Que X, Hirata K et al. The cathepsin L of Toxoplasma gondii (TgCPL) and its endogenous macromolecular inhibitor, toxostatin. Mol Biochem Parasitol 2009; 164:86-94
36. Nichols BA, Chiappino ML, Pavesio CE. Endocytosis at the micropore of Toxoplasma gondii. Parasitol Res 1994; 80:91-98
37. Botero-Kleiven S, V F, Lindh J et al. Receptor-mediated endocytosis in an apicomplexan parasite (Toxoplasma gondii). Exp Parasitol 2001; 98:134-144
38. Turk D, Janjic V, Stern I et al. Structure of human dipeptidyl peptidase I (cathepsin C): Exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. EMBO J 2001; 20:6570-6582
39. Que X, Engel JC, Ferguson D et al. Cathepsin cs are key for the intracellular survival ofthe protozoan parasite, Toxoplasma gondii. J Biol Chem 2007; 282:4994-5003
40. Fruton JS, Mycek MJ. Studies on beef spleen cathepsin C. Arch Biochem Biophys 1956; 65:11-20
41. McDonald JK, Reilly TJ, Zeitman BB et al. Cathepsin C: A chloride-requiring enzyme. Biochem Biophys Res Commun 1966; 22:771-775
42. Storch S, Pohl S, Braulke T. A dileucine motif and a cluster of acidic amino acids in the second cytoplasmic domain of the batten disease-related CLN3 protein are required for efficient lysosomal targeting. J Biol Chem 2004; 279:53625-53634
43. Illy C, Quraishi O, Wang J et al. Role ofthe occluding loop in cathepsin B activity. J Biol Chem1997; 272:1197-1202
44. Dahl SW, Halkier T, Lauritzen C et al. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing. Biochemistry 2001; 40:1671-1678
45. Leander BS, Clopton RE, Keeling PJ. Phylogeny of gregarines (Apicomplexa) as inferred from small-subunit rDNA and beta-tubulin. Int J Syst Evol Microbiol 2003; 53:345-354
46. Harper JM, Huynh MH, Coppens I et al. A cleavable propeptide influences Toxoplasma infection by facilitating the trafficking and secretion ofthe TgMIC2-M2AP invasion complex. Mol Biol Cell 2006; 17:4551-4563
47. Brydges SD, Harper JM, Parussini F et al. A transient forward-targeting element for microneme-regulated secretion in Toxoplasma gondii. Biol Cell 2008; 100:253-264
48. El Hajj H, Papoin J, Cerede O et al. Molecular signals in the trafficking of Toxoplasma gondii protein MIC3 to the micronemes. Eukaryot Cell 2008; 7:1019-1028
49. Rabenau KE, Sohrabi A, Tripathy A et al. TgM2AP participates in Toxoplasma gondii invasion of host cells and is tightly associated with the adhesive protein TgMIC2. Mol Microbiol 2001; 41:537-547
50. Brydges SD, Sherman GD, Nockemann S et al. Molecular characterization ofTgMIC5, a proteolytically processed antigen secreted from the micronemes of Toxoplasma gondii. Mol Biochem Parasitol 2000; 111:51-66
51. Bradley PJ, Ward C, Cheng SJ et al. Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. J Biol Chem 2005; 280:34245-34258
52. Goldszmid RS, Coppens I, Lev A et al. Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. J Exp Med 2009; 206:399-410
53. Que X, Wunderlich A, Joiner KA et al. Toxopain-1 is critical for infection in a novel chicken embryo model of congenital toxoplasmosis. Infect Immun 2004; 72:2915-2921
54. Shaw MK, Roos DS, Tilney LG. Cysteine and serine protease inhibitors block intracellular development and disrupt the secretory pathway of Toxoplasma gondii. Microbes Infect 2002; 4:119-132
55. Huynh MH, Carruthers VB. Tagging of endogenous genes in a Toxoplasma gondii strain lacking Ku80. Eukaryotic Cell 2009; 8:530-539
56. Agop-Nersesian C, Naissant B, Ben Rached F et al. Rab11A-controlled assembly of the inner membrane complex is required for completion of apicomplexan cytokinesis. PLoS Pathog 2009; 5:e1000270
57. Breinich MS, Ferguson DJ, Foth BJ et al. A dynamin is required for the biogenesis of secretory organelles in Toxoplasma gondii. Curr Biol 2009; 19:277-286